Biomedical Research Priorities: Who Should Decide? : Hearing Before the Subcommittee on Public Health and Safety of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, First Session ... May 1, 1997, 4. sējumsU.S. Government Printing Office, 1997 - 90 lappuses |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
academic activity advances advocacy groups allocation Alzheimer's American appropriate areas basic research believe biology biomedical research bipolar disorder breakthroughs breast cancer Bristol-Myers Squibb burden of disease centers Chairman clinical research clozapine committee CONGRES CONGRESS THE LIBRARY constituents decisionmaking decisions direct disorders dollars dopamine drug effort entists extramural eye and vision Federal field focus funding gene GRES GRESS Harold Varmus hearing human important individual industry Institutes of Health intramural issues leadership LIBRA LIBRARY OF CONGRESS medical research MIKE DeWINE million National Institutes NIH budget Parkinson's disease patient groups patient organizations percent pharmaceutical prepared statement principles programs protease public health question RARY research enterprise Research!America RESS role Rosenberg Rosenblatt schizophrenia scientific opportunities scientists Senator BINGAMAN Senator DEWINE Senator FRIST Senator Kennedy Senator MIKULSKI specific diseases Squibb Subcommittee Suttie Thank treatment understanding Varmus vision research WEINBERG
Populāri fragmenti
53. lappuse - ... better health, a need to maintain a diverse portfolio that supports work in many scientific disciplines and on a wide range of diseases, and an obligation to insure a strong scientific infrastructure, with a high quality workforce and excellent research facilities.
59. lappuse - Members of the Subcommittee: I am John Suttie, professor of biochemistry and nutritional sciences at the University of Wisconsin. I...
18. lappuse - That is not what I am talking about. I am talking about, for example, the Mad River, or the Naugatuck River, which are not navigable.
51. lappuse - Thank you for the opportunity to discuss this important issue with you today.
61. lappuse - Thank you for giving me the opportunity to appear before you today. I would be pleased to answer your questions. [Prepared statement of Mr.
52. lappuse - A commitment to support wort of the highest scientific caliber. A basic tenet of our stewardship is the pledge to maximize the return on the public's investment in research; to do this, we demand that all requests for support pass stringent review for scientific quality. • A responsibility to seiie the scientific opportunities that offer the best prospects far new knowledge and better health.
60. lappuse - Investment in biomedical research is the first and critical step in prevention, treatment and control of disease, which, in turn will lead to longer, healthier and more active lives. Without adequate funding of the NIH, progress will be slowed and suffering will be prolonged.
21. lappuse - Thank you, Mr. Chairman. I do not have any questions. I just want to open an old wound.
76. lappuse - It is caused by the degeneration of brain cells that produce dopamine, a neurochemical controlling motor function.
52. lappuse - An obligation to respond to public health needs, as judged by the incidence, severity, and cost of specific disorders.